Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 21: 1378-1382, 1975;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Usategui-Gomez, M.
Right arrow Articles by Grunberg, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Usategui-Gomez, M.
Right arrow Articles by Grunberg, E.

Clinical Chemistry, Vol 21, 1378-1382, Copyright © 1975 by the American Association for Clinical Chemistry

Simultaneous Detection of Morphine and Barbiturates in Urine by Radioimmunoassay

M. Usategui-Gomez 1, J. E. Heveran 1, R. Cleeland 1, B. McGhee 1, Z. Telischak 1, T. Awdziej 1, and E. Grunberg 1

1 Department of Diagnostic Research, Hoffmann-La Roche Inc., Nutley, N. J. 07110.

This report describes a radioimmunoassay for the simultaneous detection of morphine and barbiturates. Morphine and barbiturate antibodies, obtained from goats, were mixed with 125I-labeled antigens. By adjusting concentrations of the morphine and barbiturate antibodies and radiolabeled antigens, closely superimposed standard curves for the two drugs would be obtained. As a consequence, similar response curves were obtained for urine specimens containing morphine or barbiturates. Although concentrations as low as 25 µg/liter could be measured, to ensure against false positive reactions the test should be performed at the 100 µg/liter concentration. Unknown samples positive by the dual assay were confirmed by separately testing the specimens with the individual radioimmunoassay specific for morphine or barbiturate. Equivalency tests of urines positive for morphine, positive for barbiturates, or negative for both demonstrated complete correlation between the single and dual assays. The mixed reagent retained its sensitivity and specificity for at least three months when stored at 4 or 25 °C. The dual radioimmunoassay is a rapid, simple procedure that can be adapted to automated processes and that is suitable for largeand small-scale screening.


Key Words: toxicology • abused drugs • screening • multiple simultaneous drug assay

Submitted on October 10, 1974
Accepted on June 4, 1975






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1975 by the American Association for Clinical Chemistry.